More than one in four patients with schizophrenia experience comorbid symptoms of obsessive-compulsi...
Last year, results from a phase 3 clinical trial showed the long-acting injectable aripiprazole laur...
The Food and Drug Administration (FDA) on Tuesday issued a warning that the antipsychotic aripiprazo...
Patients with schizophrenia who take antipsychotics commonly experience serious adverse metabolic ef...
